Advanced search
Start date
Betweenand

Establishment of the hnRNPs role on schizophrenia through protein interaction network mapping

Grant number: 16/18715-4
Support type:Scholarships in Brazil - Post-Doctorate
Effective date (Start): May 01, 2017
Effective date (End): September 30, 2019
Field of knowledge:Biological Sciences - Biochemistry - Chemistry of Macromolecules
Cooperation agreement: Coordination of Improvement of Higher Education Personnel (CAPES)
Principal Investigator:Daniel Martins-de-Souza
Grantee:Mariana Fioramonte
Home Institution: Instituto de Biologia (IB). Universidade Estadual de Campinas (UNICAMP). Campinas , SP, Brazil
Associated research grant:13/08711-3 - Developing a predictive test for a successful medication response and understanding the molecular bases of schizophrenia through proteomics, AP.JP
Associated scholarship(s):18/10220-1 - In vivo cross-linking: a more comprehensive way to determine protein-protein interactions, BE.EP.PD

Abstract

Schizophrenia consists on a chronic psychiatric disorder reaching 1% of world population. It is a multifactorial disease resulting of environmental and genetic factors. The pathology molecular mechanisms are mostly unknown, therefore several methodologies such as GWAS, transcriptome and proteome has been used to study and better understand the molecular basis concerning schizophrenia.Our group compared brains from patients with schizophrenia with brains from normal individuals and showed that brains with schizophrenia presents several up- and down-regulated proteins belonging to the hnRNP class. Moreover, our group showed differential hnRNPs in oligodendrocytes when treat with clozapin, a common psychotic used in schizophrenia treatment, pointing to a role of hnRNP in schizophrenia.Therefore, this project aims to use co-immunoprecipitation and chemical cross-linking methodologies to map the interaction network of hnRNPs. Interactome studies will be performed in oligodendrocytes as well as in post mortem tissues of corpus callosum from individuals with and without schizophrenia.A second step will contemplate a functional study of identified targets in the first part of the project. The CRISPR-Cas9 method will be used to mutate interacting partners in oligodendrocytes, causing alterations in these complexes that will be correlated to their respective functions. Therefore, this project aims, through the use of two innovative approaches, to improve the biochemical knowledge about this poorly understood disease. (AU)

Matéria(s) publicada(s) na Agência FAPESP sobre a bolsa:
Study associates schizophrenia with defective processing of messenger RNA in cells 

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
GARCIA-ROSA, SHEILA; CARVALHO, BENILTON S.; GUEST, PAUL C.; STEINER, JOHANN; MARTINS-DE-SOUZA, DANIEL. Blood plasma proteomic modulation induced by olanzapine and risperidone in schizophrenia patients. JOURNAL OF PROTEOMICS, v. 224, JUL 30 2020. Web of Science Citations: 0.
REIS-DE-OLIVEIRA, G.; ZUCCOLI, G. S.; FIORAMONTE, M.; SCHIMITT, A.; FALKAI, P.; ALMEIDA, V; MARTINS-DE-SOUZA, D. Digging deeper in the proteome of different regions from schizophrenia brains. JOURNAL OF PROTEOMICS, v. 223, JUL 15 2020. Web of Science Citations: 1.

Please report errors in scientific publications list by writing to: cdi@fapesp.br.